Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients
Mato, A.R., Hill, B.T., Lamanna, N., Barr, P.M., Ujjani, C.S., Brander, D.M., Howlett, C., Skarbnik, A.P., Cheson, B.D., Zent, C.S., Pu, J.J., Kiselev, P., Foon, K., Lenhart, J., Henick Bachow, S., Winter, A.M., Cruz, A.-L., Claxton, D.F., Goy, A., Daniel, C., Isaac, K., Kennard, K.H., Timlin, C., Fanning, M., Gashonia, L., Yacur, M., Svoboda, J., Schuster, S.J., Nabhan, C.
Published in Annals of oncology (01.05.2017)
Published in Annals of oncology (01.05.2017)
Get full text
Journal Article
GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RESPONSES AND A MANAGEABLE SAFETY PROFILE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Hutchings, M., Avigdor, A., Sureda, A., Terol, M. J., Bosch, F., Corradini, P., Larsen, T. Stauffer, Domínguez, A. Rueda, Skarbnik, A., Jørgensen, J., Goldschmidt, N., Gurion, R., Zinzani, P. L., Pinto, A., Cordoba, R., Bottos, A., Huang, Z., Simko, S., Relf, J., Filézac de L’Etang, A., Sellam, G., Gritti, G.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORAMBUCIL IN TREATMENT‐NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: 5‐YEAR FOLLOW‐UP OF ELEVATE‐TN
Sharman, J. P., Egyed, M., Jurczak, W., Skarbnik, A., Patel, K., Flinn, I. W., Kamdar, M., Munir, T., Walewska, R., Fogliatto, L. M., Herishanu, Y., Banerji, V., Follows, G., Walker, P., Karlsson, K., Ghia, P., Janssens, A., Cymbalista, F., Ferrant, E., Wierda, W. G., Munugalavadla, V., Yu, T., Wang, M. H., Woyach, J. A.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P671: TREATMENT SEQUENCES AND OUTCOMES OF PATIENTS WITH CLL TREATED WITH TARGETED AGENTS IN REAL‐WORLD SETTINGS
Mato, A. R., Manzoor, B. S., Coombs, C. C., Lamanna, N., Tuncer, H. H., Brown, J. R., Roeker, L. E., Shadman, M., Allan, J. N., Ujjani, C., Eichhorst, B., Leslie, L., Fleury, I., Alhasani, H., Rhodes, J., Hill, B. T., Barr, P. M., Skarbnik, A., Davids, M. S., Bannerji, R., Fuldeore, M., Lansigan, F., Schuh, A., Pearson, L., Fox, C. P., Pivneva, I., Popadic, L., Guerin, A., Eyre, T. A.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
A PHASE 2 STUDY TO ASSESS THE SAFETY AND EFFICACY OF UMBRALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WHO ARE INTOLERANT TO PRIOR BTK OR PI3K DELTA INHIBITOR THERAPY
Mato, A.R., Schuster, S.J., Lamanna, N., Pagel, J.M., Flinn, I.W., Barrientos, J., Reeves, J.A., Cheson, B.D., Barr, P.M., Kambhampati, S., Lansigan, F., Pu, J.J., Skarbnik, A., Fonseca, G., Dorsey, C., LaRatta, N.M., Weissbrot, H., Svoboda, J., Luning Prak, E.T., Tsao, P., Sitlinger, A., Paskalis, D., Sportelli, P., Miskin, H.P., Weiss, M.S., Brander, D.M.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
PB2353: HEALTHCARE RESOURCE UTILIZATION AND COSTS OFF THERAPY WITH FIXED‐DURATION VENETOCLAX AMONG CLL PATIENTS
Allan, J. N., Skarbnik, A. P., Emechebe, N., Alhasani, H., Manzoor, B. S.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
PB2133: ASSESSING SAFETY, TOLERABILITY, AND EFFICACY OF SUBCUTANEOUS EPCORITAMAB IN NOVEL COMBINATIONS WITH ANTI‐NEOPLASTIC AGENTS IN PATIENTS WITH NON‐HODGKIN LYMPHOMA IN A PHASE 1B/2, OPEN‐LABEL STUDY
Sehn, L. H., Avivi, I., Brody, J., Yoon, D. H., Elliott, B. M., Siddani, S. R., Bai, Y., Parikh, A., Seliem, M. M., Dinh, M. H., Skarbnik, A. P.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
Ghia, P, Skarbnik, A, Miranda, M, Yong, A S, Roos, J, Hettle, R, Palazuelos-Munoz, S, Shetty, V, Kittai, A
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study
Morschhauser, Franck, Dahiya, Saurabh, Palomba, M. Lia, Martin Garcia-Sancho, Alejandro, Reguera Ortega, Juan Luis, Kuruvilla, John, Jäger, Ulrich, Cartron, Guillaume, Izutsu, Koji, Dreyling, Martin, Kahl, Brad, Ghesquieres, Hervé, Ardeshna, Kirit, Goto, Hideki, Barbui, Anna Maria, Abramson, Jeremy S., Borchmann, Peter, Fleury, Isabelle, Mielke, Stephan, Skarbnik, Alan, de Vos, Sven, Kamdar, Manali, Karmali, Reem, Viardot, Andreas, Farazi, Thalia, Fasan, Omotayo, Lymp, James, Vedal, Min, Nishii, Rina, Avilion, Ariel, Papuga, Jessica, Kumar, Jinender, Nastoupil, Loretta J.
Published in Nature Medicine (03.06.2024)
Published in Nature Medicine (03.06.2024)
Get full text
Journal Article
Magazine Article
Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study
Morschhauser, Franck, Dahiya, Saurabh, Palomba, M. Lia, Martin Garcia-Sancho, Alejandro, Reguera Ortega, Juan Luis, Kuruvilla, John, Jäger, Ulrich, Cartron, Guillaume, Izutsu, Koji, Dreyling, Martin, Kahl, Brad, Ghesquieres, Hervé, Ardeshna, Kirit, Goto, Hideki, Barbui, Anna Maria, Abramson, Jeremy S., Borchmann, Peter, Fleury, Isabelle, Mielke, Stephan, Skarbnik, Alan, de Vos, Sven, Kamdar, Manali, Karmali, Reem, Viardot, Andreas, Farazi, Thalia, Fasan, Omotayo, Lymp, James, Vedal, Min, Nishii, Rina, Avilion, Ariel, Papuga, Jessica, Kumar, Jinender, Nastoupil, Loretta J.
Published in Nature medicine (2024)
Published in Nature medicine (2024)
Get full text
Journal Article
A MATCHING‐ADJUSTED INDIRECT COMPARISON OF THE EFFICACY AND SAFETY OF ACALABRUTINIB VERSUS ZANUBRUTINIB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Ghia, P., Skarbnik, A., Miranda, M., Yong, A. S., Roos, J., Hettle, R., Palazuelos‐Munoz, S., Shetty, V., Kittai, A.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
TRANSCEND FL: Phase 2 Study Primary Analysis of Lisocabtagene Maraleucel as SecondLine Therapy in Patients with High-Risk Relapsed or Refractory Follicular Lymphoma
Morschhauser, F, Dahiya, S, Palomba, ML, Garcia-Sancho, AM, Reguera, JL, Kuruvilla, J, Jaeger, U, Cartron, G, Izutsu, K, Dreyling, M, Kahl, BS, Ghesquieres, H, Ardeshna, K, Goto, H, Barbui, AM, Abramson, JS, Borchmann, P, Fleury, I, Mielke, S, Skarbnik, A, de Vos, S, Kamdar, M, Karmali, R, Viardot, A, Farazi, T, Fasan, O, Lymp, J, Vedal, M, Nishii, R, Avilion, A, Papuga, J, Nastoupil, LJ
Published in BLOOD (2023)
Published in BLOOD (2023)
Get full text
Conference Proceeding
GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RESPONSES AND A MANAGEABLE SAFETY PROFILE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Hutchings, M., Avigdor, A., Sureda, A., Terol, M. J., Bosch, F., Corradini, P., Larsen, T. Stauffer, Domínguez, A. Rueda, Skarbnik, A., Jørgensen, J., Goldschmidt, N., Gurion, R., Zinzani, P. L., Pinto, A., Cordoba, R., Bottos, A., Huang, Z., Simko, S., Relf, J., Filézac de L’Etang, A., Sellam, G., Gritti, G.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
PF381 FACTORS IMPACTING TREATMENT SELECTION IN TREATMENT‐NAÏVE PATIENTS WITH CLL: A MULTICENTER STUDY
Rhodes, J., Sail, K., Sarraf Yazdy, M., Hill, B., Shadman, M., Tuncer, H., Winter, A., Kennard, K., Allan, J., Ujjani, C., Brander, D., Cho, S., Sharmokh, S., Dingfeng Jiang, D., Nabhan, C., Barr, P., Brown, J., Fox, C., Schuh, A., Eyre, T., Lamanna, N., Wierda, W., Skarbnik, A., Roeker, L., Bannerji, R., Evens, A., Pauff, J., Schuster, S., Follows, G., Cheson, B., Eichhorst, B., Mato, A.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in Chronic Lymphocytic Leukemia: Results from a Multi-Center Study of 683 Patients
Mato, A R, Hill, B T, Lamanna, N, Barr, P M, Ujjani, C S, Brander, D M, Howlett, C, Skarbnik, A P, Cheson, B D, Zent, C S, Pu, J J, Kiselev, P, Foon, K, Lenhart, J, Henick Bachow, S, Winter, A M, Cruz, A-L, Claxton, D F, Goy, A, Daniel, C, Isaac, K, Kennard, K H, Timlin, C, Fanning, M, Gashonia, L, Yacur, M, Svoboda, J, Schuster, S J, Nabhan, C
Published in Annals of oncology (25.01.2017)
Get full text
Published in Annals of oncology (25.01.2017)
Journal Article
Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
Biran, Noa, Zhang, Shijia, Rowley, Scott D., Vesole, David H., Donato, Michele L., Skarbnik, Alan P, Richter, Joshua R, Pecora, Andrew L., Siegel, David S
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article